Capital Guardian Trust’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Capital Guardian Trust’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,000	Closed	-$6K	–	762
2015 Q3	$6K	Hold	12,000	–	–	﹤0.01%	637
2015 Q2	$6K	Hold	12,000	–	–	﹤0.01%	638
2015 Q1	$9K	Hold	12,000	–	–	﹤0.01%	629
2014 Q4	$6K	Hold	12,000	–	–	﹤0.01%	485
2014 Q3	$7K	Hold	12,000	–	–	﹤0.01%	516
2014 Q2	$15K	Hold	12,000	–	–	﹤0.01%	457
2014 Q1	$22K	Hold	12,000	–	–	﹤0.01%	422
2013 Q4	$19K	Hold	12,000	–	–	﹤0.01%	446
2013 Q3	$29K	Buy	+12,000	New	+$33.2K	﹤0.01%	376

Other funds holding ONCY

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

KWMG

King Wealth Management Group Naples, Florida $914M AUM 24.3% 1-Year Est. Return

Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

Capital Guardian Trust's ONCY Position: Q4 2015 in Review

Capital Guardian Trust sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 12,000 shares — an estimated $6K sold.

Capital Guardian Trust first reported a position in ONCY in Q3 2013 and held it in 9 quarters. The position peaked at $29K in Q3 2013. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

Capital Guardian Trust reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
Capital Guardian Trust sold 12,000 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $6K.
Capital Guardian Trust first reported a position in ONCOLYTICS BIOTECH INC in Q3 2013 and held it in 9 quarters.
Capital Guardian Trust's ONCOLYTICS BIOTECH INC position peaked at $29K in Q3 2013.
7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Capital Guardian Trust's 13F filing for Q4 2015, filed 12 Feb 2016.